Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease

Blood

Volumn 97, Issue 12, 2001, Pages 3738-3745

  Dinauer, Mary C ^a,b   Gifford, Mary A ^a   Pech, Nancy ^a   Li, Ling Lin ^a   Emshwiller, Patricia ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; BONE MARROW TRANSPLANTATION; BURKHOLDERIA CEPACIA; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE TRANSFER; HOST RESISTANCE; IMMUNE RESPONSE; LEUKOCYTE COUNT; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; RETROVIRUS; STAPHYLOCOCCUS AUREUS; X CHROMOSOME LINKAGE;

EID: 0035877972     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.12.3738     Document Type: Article

References (47)

1. Dinauer M. The phagocyte system and disorders of granulopoiesis and granulocyte function. In Nathan D, Orkin S, eds. Hematology of Infancy and Childhood. Vol 1. 5th ed. Philadelphia, PA: WB Saunders; 1998:889-967.
2. Malech H, Nauseef W. Primary inherited defects in neutrophil function: etiology and treatment. Semin Hematol. 1997;34:279-290.
3. Curnutte JT. Molecular basis of the autosomal recessive forms of chronic granulomatous disease. Immunodefic Rev. 1992;3:149-172.
4. Roos D, Curnutte J. Chronic granulomatous disease. In Ochs H, Smith C, Puck J, eds. Primary Immunodeficiency Diseases, A Molecular and Genetic Approach. New York, NY: Oxford University Press; 1999:353-374.
5. Roos D, de Boer M, Kuribayashi F, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood. 1996;87:1663-1681.
6. Finn A, Hadzik N, Morgan G, Strobel S, Levinsky R. Prognosis of chronic granulomatous disease. Arch Dis Child. 1990;65:942-945.
7. Fischer A, Segal A, Seger R, Weening R. The management of chronic granulomatous disease. Eur J Pediatr. 1993;152:896-899.
8. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79:170-200.
9. Weening R, Adriaansz L, Weemaes C, Lutter R, Roos D. Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b-positive neutrophils. J Pediatr. 1985;107:102-104.
10. phox-deficient model of chronic granulomatous disease. Blood. 1997;89:2268-2275.
11. Weinberg K, Kohn D. Gene therapy for congenital immunodeficiency diseases. Immunol Allergy Clin North Am. 1996;16:453-476.
12. Malech H, Bauer T, Hickstein D. Prospects for gene therapy of neutrophil defects. Semin Hematol. 1997;34:355-361.
13. Kume A, Dinauer M. Gene therapy for chronic granulomatous disease. J Lab Clin Med. 1999;135:122-128.
14. Kamani N, August CS, Campbell DE, Hassan NF, Douglas SD. Marrow transplantation in chronic granulomatous disease: an update, with 6-year follow-up. J Pediatr. 1988;113:697-700.
15. Ho C, Vowels M, Lockwood L, Ziegler J. Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease. Bone Marrow Transplant. 1996;18:213-215.
16. Calvino M, Maldonado M, Otheo E, Munoz A, Couselo J, Burgaleta C. Bone marrow transplantation in chronic granulomatous disease. Eur J Pediatr. 1996;155:877-879.
17. Hobbs J, Monteil M, McCluskey D, Jurges E, Tumi M. Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor. Eur J Pediatr. 1992;151:806-810.
18. Woodman R, Teoh D, Johnston F, et al. X-linked carriers of gp91-phox chronic granulomatous disease (CGD): clinical and potential therapeutic implications of extreme unbalanced X chromosome inactivation. Blood. 1995;86:27a.
19. Johnston RI, Harbeck R, Johnston RI. Recurrent severe infection in a girl with apparently variable expression of mosaicism for chronic granulomatous disease. J Pediatr. 1985;106:50-55.
20. Mills E, Rholl K, Quie P. X-linked inheritance in females with chronic granulomatous disease. J Clin Invest. 1980;66:332-340.
21. Roos D, de Boer M, Borregard N, et al. Chronic granulomatous disease with partial deficiency of cytochrome b558 and incomplete respiratory burst: variants of the X-linked, cytochrome b558-negative form of the disease. J Leukoc Biol. 1992;51:164-171.
22. Styrt B, Klempner M. Late-presenting variant of chronic granulomatous disease. Pediatr Infect Dis J. 1984;3:556-559.
23. Newburger PE, Luscinskas FW, Ryan T, et al. Variant chronic granulomatous disease: modulation of the neutrophil defect by severe infection. Blood. 1986;68:914-919.
24. Lew PD, Southwick FS, Stossel TP, Whitin JC, Simons E, Cohen HJ. A variant of chronic granulomatous disease: deficient oxidative metabolism due to a low-affinity NADPH oxidase. N Engl J Med. 1981;305:1329-1333.
25. Bohler M-C, Seger R, Mouy R, Vilmer E, Fischer A, Griscelli C. A study of 25 patients with chronic granulomatous disease: a new classification by correlating respiratory burst, cytochrome b and flavoprotein. J Clin Immunol. 1986;6:136-145.
26. - variant chronic granulomatous disease. Blood. 1995;86:3575-3582.
27. Woodman R, Newburger P, Anklesaria P, et al. A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells. Blood. 1995;85:231-241.
28. Seger R, Tiefnauer L, Matsunga T, Wildfeuer A, Newburger P. Chronic granulomatous disease due to granulocytes with abnormal NADPH oxidase activity and deficient cytochrome-b. Blood. 1983;61:423-428.
29. Pollock J, Williams D, Gifford M, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet. 1995;9:202-209.
30. phox mouse knock-out model of chronic granulomatous disease. J Exp Med. 1995;182:751-758.
31. Morgenstern D, Gifford M, Li L, Doerschuk C, Dinauer M. Absence of respiratory burst in x-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med. 1997;185:207-218.
32. phox into bone marrow cells rescues in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease. Blood. 1997;89:41-48.
33. Dinauer M, Li L, Bjorgvinsdottir H, Ding C, Pech N. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease. Blood. 1999;94:914-922.
34. phox-/- mouse model of chronic granulomatous disease. Infect Immun. 2000;68:2374-2378.
35. Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155-169.
36. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to aspergillus. J Clin Invest. 1982;69:617-631.
37. Schaffner A. Macrophage-Aspergillus interactions. In Zwilling BS, Eisenstein TK, eds. Macrophage-Pathogen Interactions. Interactions. Vol 60, Immunology Series . New York, NY: Marcel Decker; 1994:545-552.
38. O'Neill K, Herman J, Modlin J, Moxon E, Chir B, Winkelstein J. Pseudomonas cepacia: an emerging pathogen in chronic granulomatous disease. J Pediatr. 1986;108:940-942.
39. Speert D, Bond M, Woodman R, Curnutte J. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J Infect Dis. 1994;170:1524-1531.
40. 588. J Clin Invest. 1994;94:1205-1211.
41. Mardiney M, Malech H. Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation: implications for gene therapy. Blood. 1996;87:4049-4056.
42. Miyazaki S, Shin H, Goya N, Nakagawara A, Identification of a carrier mother of a female patient with chronic granulomatous disease. J Pediatr. 1976;89:784-786.
43. Pochcial M, Schiff D, Nelson R, Day N, Good R. Symptomatic carrier of X-linked chronic granulomatous disease (CGD). J Allerg Cl. 1997;99: S75.
44. Rex J, Bennett J, Galiin J, Malech H, Melnick D. Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. J Infect Dis. 1990;162:523-528.
45. Schapiro B, Newburger P, Klempner M, Dinauer M. Chronic granulomatous disease in an elderly man: an X-linked cytochrome b positive variant. N Engl J Med. 1991;325:1786-1790.
46. Borregaard N, Cross AR, Herlin T, Jones OT, Segal AW, Valerius NH. A variant form of X-linked chronic granulomatous disease with normal nitroblue tetrazolium slide test and cytochrome b. Eur J Clin Invest. 1983;13:243-248.
47. Jendrossek V, Ritzel A, Neubauer B, Heyden S, Gahr M. An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity. Eur J Haematol. 1997;58:78-85.